MRK Upgraded
MRK upgraded to buy from neutral at Robinson Humphrey (32.61)
Cites the FDA vote on Vioxx; believes MRK shares may have hit a bottom.
« Home | FTC to look at J&J-Guidant »
Tuesday, February 22, 2005
Post a Comment